Optimal antithrombotic treatment in patients with an indication for long-term anticoagulation undergoing coronary artery stenting.

about

Optimal antithrombotic treatment in patients with an indication for long-term anticoagulation undergoing coronary artery stenting.

Item

http://www.wikidata.org/entity/Q40347846

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Optimal antithrombotic treatme ...... oing coronary artery stenting.

@en

type

Item

label

Optimal antithrombotic treatme ...... oing coronary artery stenting.

@en

prefLabel

Optimal antithrombotic treatme ...... oing coronary artery stenting.

@en

P1476

Optimal antithrombotic treatme ...... oing coronary artery stenting.

@en

P2093

Andrea Rubboli

http://www.w3.org/2001/XMLSchema#string

Giuseppe Di Pasquale

http://www.w3.org/2001/XMLSchema#string

P2860

Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation

Meta-analysis of trials comparing oral anticoagulation and aspirin versus dual antiplatelet therapy after coronary stenting. Clues for the management of patients with an indication for long-term anticoagulation undergoing coronary stenting

Aspirin alone antiplatelet regimen after intracoronary placement of the Carbostent: the ANTARES study

Oral anticoagulation for acute coronary syndromes

Safety of an aspirin-alone regimen after intracoronary stenting with a heparin-coated stent: final results of the HOPE (HEPACOAT and an Antithrombotic Regimen of Aspirin Alone) study

Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin

Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Costs and clinical outcomes associated with low-molecular-weight heparin vs unfractionated heparin for perioperative bridging in patients receiving long-term oral anticoagulant therapy.

P304

205-213

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/14796678.2.2.205

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19804077

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation